Adrian Sferle @adriansferle
All tweets = my opinion. San Francisco, CA Joined January 2011-
Tweets426
-
Followers941
-
Following914
-
Likes153
Beta cell loss is a key cause of type 2 and type 1 diabetes. 🧬The menin protein is thought to function as a key regulator of beta cell health. – menin.org #T2D #Diabetes #Type2Diabetes #TeamFusion $BMEA
#HappyIndependenceDay from all of us at Biomea Fusion!
FDA's Dr. Lisa Yanoff emphasizes the urgency for antidiabetic solutions as the agency presents new draft guidelines for diabetes -- Biomea Fusion aims to address a root cause of diabetes with BMF-219. 💊 biomeafusion.com #T2D #biotech #ADA2023 #biotechnews #medicalnews
Biomea CEO, Thomas Butler, expects to share late-breaking clinical data from COVALENT-111 at the upcoming American Diabetes Association Scientific Sessions in San Diego. Follow us for updates - bit.ly/3VvWi2A #Biotech #T2D #Type2Diabetes #Diabetes #ADA2023 $BMEA
Chef Curry cooked 50 points, serving the newly dethroned Sacramento Kings a cold dish of middle-seat economy Aeroméxico tickets to Cancún. Exeunt SMF, Gate 12, Sacramento. #DubNation
🚨 Don't miss our poster presentation at #AACR23 happening now until 5pm EST. ▶️ Location: Poster Section 15 📄 Abstract/Poster: 4939/17 💡 Find out more at bit.ly/3KFq8fQ #AACR #AACR2023 #BMEA #BiomeaFusion #oncology #medonc
We hope you're enjoying the wonderful weekend with your friends and family. #PresidentsDay
Biomea Fusion's leadership team has a history commercial success. Find out more at biomeafusion.com #JMPHC23 #JPM23 #JPM2023
If you're at #JPMHC23, discover Biomea Fusion's covalent compound therapeutics and technology. Visit us at biomeafusion.com @Nasdaq : $BMEA #JPM23 #JPMorgan #healthcare #JPM2023 #biotechnews
We earned our spot on the Nasdaq Biotech Index. If you're at #JMPHC23, make sure to meet with Biomea Fusion's all-star leadership team and discover more about our small covalent molecule therapeutics. biomeafusion.com #JPM23 #JPM2023 #biotech #biotechnews #healthcare
"In FLT3-driven AML cell lines, three-hour exposure to BMF-500 produced complete phospho-FLT3 inhibition, which was maintained following washout of the compound." 👉 Read more about our preclinical data on BMF-500 - bit.ly/3uJwzXH 👉 At #ASH22? Visit us at booth 3342
(Sound on) 🎧 Did you know inhibition of the menin protein leads to interesting preclinical results for hematological malignancies? 👉 Like the song says, "visit our booth thirty-three forty-two" (3342) by AbbVie, to chat with us. #ASH22 #ASH2022 #hematology #oncology #leukemia
Did you see our ad in @BloodAdvances about our small molecule investigational therapies for #MLLr? One day this may be a potential step forward in the fight against hematological malignancies — visit us at booth 3342 @ #ASH22. #ASH2022 #oncology #hematology